title: Lower urinary tract dysfunction: From basic science to clinical management. Foreword.
authors.affiliation: Department of Pharmacology and Chemical Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
authors.forename: William C
authors.initials: WC
authors.lastname: de Groat
mesh_terms: D000083:Acetanilides / Q000627:therapeutic use; D058667:Adrenergic beta-3 Receptor Agonists / Q000627:therapeutic use; D000344:Afferent Pathways / Q000187:drug effects / Q000503:physiopathology*; D015415:Biomarkers / Q000032:analysis; D001905:Botulinum Toxins / Q000627:therapeutic use; D002243:Carbolines / Q000627:therapeutic use; D006801:Humans; D059411:Lower Urinary Tract Symptoms / Q000188:drug therapy / Q000503:physiopathology*; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use; D015398:Signal Transduction; D000068581:Tadalafil; D013844:Thiazoles / Q000627:therapeutic use; D053201:Urinary Bladder, Overactive / Q000188:drug therapy / Q000503:physiopathology; D019459:Urothelium / Q000187:drug effects / Q000503:physiopathology
chemical_list: D000083:Acetanilides; D058667:Adrenergic beta-3 Receptor Agonists; D015415:Biomarkers; D002243:Carbolines; D058986:Phosphodiesterase 5 Inhibitors; D013844:Thiazoles; D000068581:Tadalafil; D001905:Botulinum Toxins; C520025:mirabegron